## EG: Everest Group, Ltd. - XLF: Financial Services

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 5.8% in upper entry zone (3.0-6.0%), top 9% cross-sectional ranking. Short-term MRS_5 (2.3%) confirms momentum alignment. Strong momentum (+2.8% 5-day acceleration).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($315.71)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Zacks Research Lowers Earnings Estimates for Everest Group**
- Source: MarketBeat | 20251217T131821 | Somewhat-Bearish | Relevance: 100%
- Zacks Research has lowered its Q1 2026 EPS estimates for Everest Group (NYSE:EG) to $14.54 from $15.38 and issued a "Strong Sell" rating. Despite this, Everest Group recently reported strong Q4 revenue of $4.32 billion, exceeding estimates, though EPS missed expectations. The company also announced a quarterly dividend of $2.00 per share and saw significant insider purchases in October.

**2. Everest Group (NYSE:EG) Upgraded by Mizuho to Hold Rating**
- Source: MarketBeat | 20251217T131621 | Neutral | Relevance: 100%
- Mizuho initiated coverage on Everest Group (NYSE:EG) with a "neutral" rating and a $359.00 price target, suggesting a potential upside of 9.66%. Other analysts have adjusted their ratings and price targets, with the consensus remaining "Hold" and an average price target of $367.87. Additionally, significant insider stock acquisitions by directors Allan Levine and William F. Galtney, Jr. have been reported.

**3. AIG secures renewal rights for Everest Group retail portfolios in EU**
- Source: Insurance Business | 20251216T023604 | Neutral | Relevance: 100%
- AIG has received regulatory approval to acquire the renewal rights for a majority of Everest Group's retail insurance portfolios in EU countries, following a deal announced in October for $300 million. This transaction, representing about $2 billion of global premium, allows AIG to expand its retail insurance book and strengthen its presence in key global markets without significantly increasing costs or capital requirements. AIG will assume renewal capacity for eligible policies starting January 1, 2026, with Everest Group retaining liability exposure and claims administration.

**4. Mizuho initiates Everest Group stock coverage with Neutral rating By Investing.com**
- Source: Investing.com Australia | 20251216T000804 | Somewhat-Bearish | Relevance: 100%
- Mizuho has initiated coverage on Everest Group (NYSE:EG) with a Neutral rating and a price target of $359.00, citing concerns over the company's history of reserve strengthening and recent retrenchment in its Insurance operations. Despite these challenges, Everest Group maintains a 2.45% dividend yield and has sustained dividend payments for 31 consecutive years, though analysts anticipate a sales decline and potential premium pressure. The firm also highlighted Everest's strategic pivot towards Reinsurance, departing from its prior focus on higher-multiple specialty insurance.

**5. TD Cowen Cuts Everest Group (NYSE:EG) Price Target to $365.00**
- Source: MarketBeat | 20251215T173207 | Somewhat-Bearish | Relevance: 100%
- TD Cowen reduced its price target for Everest Group (NYSE:EG) to $365.00 from $400.00 while maintaining a "hold" rating, suggesting a 12.36% upside. This adjustment follows Everest Group's recent earnings miss, reporting $7.54 EPS against an expected $13.39, despite beating revenue estimates with $4.32 billion. Analyst consensus for Everest Group is a "Hold" with an average target price of $368.50.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Mizuho | $359 | $0 | 0% |
| 2025-12-15 | TD Cowen | $365 | $400 | -9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Mizuho | init | Neutral |
| 2025-12-15 | TD Cowen | main | Hold |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Vanguard Group Inc: 13.1% (-1.0%)
- Blackrock Inc.: 8.1% (-2.9%)
- AQR Capital Manageme: 4.8% (+70.3%)
- State Street Corpora: 4.5% (-0.7%)
- Vulcan Value Partner: 3.4% (+13.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +2.8% over 5 days suggests accumulation.

### Fundamentals

Forward P/E 5.9x attractive for 24% earnings growth. Balance sheet: strong liquidity (11.3x). Revenue declining -6% YoY, concerning. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (3 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.8B |
| Beta | 0.38 |
| 52W Range | $302.44 - $373.23 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | -50.00 |
| Forward P/E | 5.9 |
| Current P/E | 7.4 |
| YoY Growth | 24.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 3.0% to 5.8% (+2.8% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 90th percentile. MRS_5 at 2.3% confirms short-term momentum alignment. Below SMA200 (0.97x), long-term trend not supportive. MACD histogram positive (2.78), confirming momentum. RSI neutral at 60. OFD pattern: +SBN (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 5.81% (CS: 91) | Strong |
| RSI_14 | 59.7 | Neutral |
| MACD Histogram | 2.78 | Bullish |
| vs SMA20 | 1.041x | Above |
| vs SMA50 | 1.007x | Above |
| vs SMA200 | 0.968x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $328.59
- **Stop Loss:** $315.71 (3.9% risk)
- **Target:** $347.91 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 83
- **Position Value:** $27,272.97
- **Portfolio %:** 27.27%
- **Risk Dollars:** $1,080.00
- **Risk Per Trade:** 1.08%
- **Modifiers:** L1 90% | L2 120% | Combined 1.08x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

**Next:** 2026-02-02 (Est: $13.08)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $14.52 | $7.54 | -48.1% |
| 2025Q2 | $14.82 | $17.36 | +17.1% |
| 2025Q1 | $7.74 | $6.45 | -16.7% |
| 2024Q4 | $-17.42 | $-18.39 | -5.6% |

---
*RULE-based L3 | 2026-01-07 01:40 | MRS_10*